what does neuland laboratories do

Neuland Laboratories is a contract development and manufacturing organization (CDMO) that provides end-to-end support for pharmaceutical and biotech companies, from molecule development to commercialization, catering to both domestic and international markets.

what sector is neuland laboratories in

Neuland Laboratories operates in the pharmaceutical sector, specifically as a contract development and manufacturing organization (CDMO) serving global clients.

when was neuland laboratories founded

Neuland Laboratories was founded in 1984 and is headquartered in Hyderabad, India.

who owns neuland laboratories

Neuland Laboratories is publicly listed on the National Stock Exchange of India (NSE: NEULANDLAB) and is owned by its shareholders, with the company being a publicly traded entity.

Neuland Laboratories Limited (NEULANDLAB) Share Price Today — ₹16,932.65

Neuland Laboratories Limited (NEULANDLAB) live stock price is ₹16,932.65. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Neuland Laboratories Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Neuland Laboratories Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

NEULANDLAB

BSE

Neuland Laboratories Limited

Healthcare· Pharmaceuticals & Biotechnology· INE794A01010· Scrip: 524558

EN हिन्दी ગુજરાતી मराठी

₹16,932.65

▲ 241.65 (+0.00%)

2026-06-10

BSE

₹16,932.65

▲ 241.65

+0.00%

233 trading days · 1Y period

TODAY (BSE)

Open17,344.65

High17,344.65

Low16,880.60

Prev Close17,174.30

Volume1,043

Value₹1.8Cr

L: 16,880.60H: 17,344.65

Info

Face Value₹10

Listed2008-10-13

ISININE794A01010

SeriesA

BSE Scrip524558

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue+28.05%

PAT+209.31%

EPS+209.30%

Profitability

EBITDA Margin43.3%

Net Margin25.5%

TTM EBITDA M.35.2%

TTM Net M.19.6%

Dividend

Yield—

Latest DPS₹12

Payout Ratio15.2%

Growth-14.29%

TTM Revenue

₹1533 Cr

TTM EBITDA

₹539 Cr

TTM PAT

₹300 Cr

TTM EPS

₹234.09

Rev/Share

₹1195.3

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	398 Cr	330 Cr	172 Cr	128 Cr	102 Cr	₹79.18
2024-09-30	311 Cr	266 Cr	83 Cr	49 Cr	33 Cr	₹25.60
2024-06-30	440 Cr	335 Cr	147 Cr	130 Cr	98 Cr	₹76.65
2024-03-31	385 Cr	298 Cr	137 Cr	92 Cr	68 Cr	₹52.66
2023-12-31	393 Cr	290 Cr	146 Cr	104 Cr	81 Cr	₹63.44
2023-09-30	418 Cr	299 Cr	173 Cr	122 Cr	89 Cr	₹69.56
2023-03-31	407 Cr	305 Cr	154 Cr	110 Cr	85 Cr	₹65.90
2022-12-31	269 Cr	231 Cr	63 Cr	39 Cr	31 Cr	₹23.81

Shareholding Pattern

CURRENT — 2026-03-31

Promoter32.6%

FII20.5%

DII15.8%

Public67.4%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-07-18	Dividend	Dividend - Rs 12 Per Share
2024-07-12	Dividend	Annual General Meeting/Dividend - Rs 14 Per Share
2023-07-11	Dividend	Annual General Meeting/Dividend - Rs 10 Per Share
2022-07-14	Dividend	Annual General Meeting/Dividend - Rs 5 Per Share
2021-06-29	Dividend	Annual General Meeting/Dividend - Rs 3 Per Share
2020-11-10	Dividend	Interim Dividend - Rs 2 Per Share
2020-07-02	Other	Annual General Meeting
2020-02-18	Dividend	Interim Dividend - Rs 2 Per Share
2019-06-27	Dividend	Annual General Meeting/Dividend - Rs 1.20 Per Share
2018-08-03	Other	Annual General Meeting
2017-12-21	Other	Annual General Meeting (Date Revised)
2016-08-04	Dividend	Annual General Meeting/ Dividend - Rs 2/- Per Share
2015-08-06	Dividend	Annual General Meeting/Dividend Rs 1.50 Per Share
2014-08-13	Rights	Rights Issue 4 : 25 @ Premium Rs 194/- Per Equity Share
2014-06-16	Dividend	Annual General Meeting/Final Dividend Rs.1.50 Per Share And Special Dividend Rs.1.50 Per Share
2013-07-24	Dividend	Annual General Meeting And Dividend Rs.1.20 Per Share
2012-08-03	Other	Annual General Meeting
2012-03-21	Rights	Rights 5:12 @ Premium Rs.35/- Per Share
2011-07-29	Other	Annual General Meeting
2010-07-22	Other	Annual General Meeting

Earnings Transcripts

Transcript of the Earnings Call conducted on May 12, 2026

16 May 2026NSE50K chars

Read →

Neuland Laboratories Limited has informed the Exchange about Investor Presentation

12 May 2026NSE28K chars

Read →

Q4FY26 Earnings Call Intimation

29 Apr 2026NSE2K chars

Read →

Audio Recording of the Earnings call conducted on November 7, 2025

7 Nov 2025NSE1K chars

Read →

Neuland Laboratories Limited has informed the Exchange about Investor Presentation

7 Nov 2025NSE27K chars

Read →

Neuland Laboratories Limited has informed the Exchange about Investor Presentation

31 Jul 2025NSE26K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	17,280.00	17,333.00	16,881.00	16,946.00	17,369
2026-06-03	16,993.00	17,380.00	16,925.00	16,992.00	26,919
2026-05-27	17,178.00	17,360.00	16,710.00	16,772.00	28,207
2026-05-26	16,800.00	17,399.00	16,799.00	17,071.00	58,286
2026-05-25	16,785.00	17,000.00	16,650.00	16,758.00	25,774
2026-05-22	16,773.00	17,250.00	16,326.00	16,693.00	64,311
2026-05-21	16,730.00	16,844.00	16,387.00	16,690.00	30,074
2026-05-20	16,690.00	17,040.00	16,525.00	16,624.00	31,610
2026-05-19	16,460.00	16,866.00	16,244.00	16,790.00	49,682
2026-05-18	16,590.00	16,747.00	16,260.00	16,327.00	38,167
2026-05-15	16,880.00	16,880.00	15,900.00	16,590.00	1.05L
2026-05-14	16,601.00	16,999.00	16,361.00	16,680.00	1.09L
2026-05-13	18,305.00	18,305.00	16,317.00	16,497.00	4.33L
2026-05-12	17,501.00	17,753.00	16,905.00	17,003.00	1.06L
2026-05-11	17,768.00	18,180.00	17,501.00	17,550.00	97,004
2026-05-08	17,286.00	17,765.00	17,222.00	17,666.00	89,796
2026-05-07	17,032.00	17,500.00	17,032.00	17,285.00	67,067
2026-05-06	16,281.00	17,226.00	16,210.00	17,032.00	1.07L
2026-05-05	16,300.00	16,482.00	16,045.00	16,204.00	60,951
2026-05-04	15,100.00	16,471.00	15,100.00	16,124.00	2.08L
2026-04-30	14,605.00	15,040.00	14,464.00	15,003.00	26,786
2026-04-29	14,640.00	14,803.00	14,503.00	14,656.00	18,668
2026-04-28	14,785.00	14,865.00	14,400.00	14,445.00	15,694
2026-04-27	14,449.00	14,949.00	14,307.00	14,755.00	32,555
2026-04-24	14,900.00	15,087.00	14,283.00	14,405.00	28,158
2026-04-23	15,067.00	15,428.00	14,900.00	14,977.00	22,665
2026-04-22	14,994.00	15,325.00	14,701.00	15,067.00	28,246
2026-04-21	15,250.00	15,491.00	14,848.00	14,920.00	30,894
2026-04-20	15,298.00	15,438.00	14,950.00	15,202.00	29,072
2026-04-17	15,010.00	15,414.00	14,955.00	15,295.00	24,926

Frequently Asked Questions

About

Neuland Laboratories Limited, a contract development and manufacturing organization (CDMO) based in Hyderabad, specializes in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and peptide APIs for the global pharmaceutical and biotech industries. The company, founded in 1984, supports clients in designing, developing, and manufacturing complex APIs, serving over 500 organizations worldwide and contributing significantly to healthcare solutions.